RET fusions are recurrent somatic alterations in 6–20% of differentiated thyroid cancer (DTC) of papillary histology and occur in a smaller percentage (1–2%) of lung adenocarcinoma [5]. The gene discussed is RET; the disease is lung adenocarcinoma.